临床与超声多模态数据在预测肝细胞癌根治性治疗后复发中的价值
回顾性纳入101例符合米兰标准并接受根治性治疗的肝细胞癌患者,采集临床参数、二维剪切波弹性成像肝脏硬度值及超声造影增强模式,用Cox模型分析复发相关因素并构建预测模型。二维剪切波弹性成像、超声造影增强模式和临床参数均为早期复发的独立预测因素,联合多模态模型对早期复发的拟合优度最佳。
要点
- 二维剪切波弹性成像、超声造影增强模式及临床参数均为肝细胞癌早期复发的独立预测因素。
- 超声造影-临床模型在2至7个月预测早期复发的AUC较高,剪切波弹性成像-临床模型在9至12个月AUC较高。
- 联合超声造影、剪切波弹性成像与临床参数的多模态模型对早期复发的拟合优度优于其他模型。
核心结论
- 超声造影增强模式和二维剪切波弹性成像为肝细胞癌早期复发的独立预测因素,二者在不同时间点贡献预测效能,包含多源数据的多模态模型对早期复发的拟合优度最佳。
研究设计与样本
- 回顾性纳入101例符合米兰标准并接受根治性治疗的肝细胞癌患者,采集临床参数、二维剪切波弹性成像肝脏硬度值及超声造影增强模式,采用Cox比例风险模型分析复发相关因素并构建临床模型、超声造影-临床模型、剪切波弹性成像-临床模型及超声造影-剪切波弹性成像-临床模型。
诊断标准与关键数值
- 二维剪切波弹性成像、超声造影增强模式及临床参数(脾长、多发肿瘤、甲胎蛋白、白蛋白、凝血酶原时间)与早期复发独立相关(所有P值<0.05);多发肿瘤和白蛋白下降独立影响晚期复发;以时间依赖AUC评价模型预测早期复发的效能。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The objective of the work described here was to assess the value of the combination of pre-operative multimodal data-including clinical data, contrast-enhanced ultrasound (CEUS) information and liver stiffness measurement (LSM) based on 2-D shear wave elastography (SWE)-in predicting early (within 1 y) and late (after 1 y) recurrence of hepatocellular carcinoma (HCC) after curative treatment.
METHODS: We retrospectively included 101 patients with HCC who met the Milan criteria and received curative treatment. The multimodel data from clinical parameters, LSM by 2-D SWE and CEUS enhancement patterns were collected. The association between different variables in HCC recurrence was accessed using a Cox proportional hazard model. On the basis of the independent factors of early recurrence, models with different source variables were established (Clinical Model, CEUS-Clinical Model, SWE-Clinical Model, CEUS-SWE-Clinical Model). The goodness-of-fit of models was evaluated and the performance trends of different models were calculated by time-dependent area under the curve (AUC).
RESULTS: Two-dimensional SWE, CEUS enhancement patterns and clinical parameters (spleen length, multiple tumors, α-fetoprotein, albumin and prothrombin time) were independently associated with early recurrence (all p values <0.05). Multiple tumors and a decrease in albumin independently contributed to the late recurrence. The model fit of CEUS-SWE-Clinical Model was superior to other models in predicting early recurrence (all p values <0.05). The AUCs of the CEUS-Clinical Model were higher from 2 mo to 7 mo, while the SWE-Clinical Model had higher AUCs from 9 mo to 12 mo.
CONCLUSION: CEUS enhancement patterns and 2-D SWE were independent predictors of HCC early recurrence as the two factors contributed to the predictive performance at different times. The multimodal model, which included diverse data in predicting early HCC recurrence, had the best goodness-of-fit.
引用
- Huang, Li, Huang, et al. Value of Multimodal Data From Clinical and Sonographic Parameters in Predicting Recurrence of Hepatocellular Carcinoma After Curative Treatment. Ultrasound Med Biol. 2023. PMID: 37164891. doi:10.1016/j.ultrasmedbio.2023.04.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。